BENECEL K15 M PH CR is used in matrix and controlled release formulation. Hypromellose, hydrophilic release retardant, 2208 type substitution with medium viscosity and finer particle size.

BENECEL™ K100M PH DC is a directly compressible (DC) HPMC grade. HPMC is the most widely used polymer in hydrophilic matrix systems with widespread use in controlled-release dosage forms. BENECEL™ DC HPMC grades offer good powder flow, content uniformity, and compressibility, making them well suited for direct compression.

METOLOSE® SR 90SH-15000SR provides a genuine consistency in Sustained release (matrix tablets). It can be used for semi solid drug products. For Hydrophilic matrix formulation of API and METOLOSE® SR to extend the dissolution. The dosage forms can be obtained by direct compression or granulation process. METOLOSE® SR has specifications of particle size which can be suitable for sustained release application. Dissolution profile can be easily adjusted by selecting appropriate grade. Recommendable amount of METOLOSE® SR is more than 20% in the formulation in order to form the stable gel layer.

METOLOSE® SR is designed exclusively for a hydrophilic matrix agent. It has tighter specifications compared to the regular METOLOSE® grades. The hydrophilic matrix system is the simplest sustained-release technology for oral dosage forms, consisting essentially of a drug and a water-soluble, highly viscous polymer. METOLOSE® SR has a high level of consistency in its product quality.